Dr Kellen joins Valeant management team
This article was originally published in Scrip
Executive Summary
Valeant Pharmaceuticals has appointed Dr Ari Kellen to its executive management team as executive vice-president/company group chair, effective 1 January 2014. Dr Kellen was previously a senior partner at McKinsey & Company. He has led numerous strategy, organization and performance improvement studies for healthcare companies.